Delivery Order SPE2DB22D3016-SPE2DB24FBDU6

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $11,223.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,162,774 units of 0.3 mg epinephrine auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,128.60 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,339,573 units of epinephrine 0.3 mg auto-injector devices. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $1,786.95 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4,565,536,694 units of epinephrine 0.3 mg auto-injectors. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,089,587 units of Epinephrine 0.3 mg auto-injector devices. The $4,485.90 award has a completion date of March 28, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical as the prime...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
The Defense Logistics Agency (DLA) awarded a delivery order worth $2,875.50 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,837,064 units of Epinephrine 0.3 mg auto-injectors. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
The Defense Logistics Agency (DLA) awarded a $16,563.32 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,661,114 units of Epinephrine 0.3 mg Auto-Injectors. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of an Epinephrine 0.15 mg auto-injector product. The award, valued at $1,794.36, has an ultimate completion date of April 4, 2024. This delivery order was issued under an existing Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a $1,494.50 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,558,189,968 units of epinephrine 0.3 mg auto-injectors. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,184,277 units of Epinephrine 0.3 mg auto-injectors. The $11,219.50 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBDU6
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $5,184.93 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector devices. This order is under a larger Indefinite Delivery Contract valued up to $999,999,999 through December 2025, which AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The award has no set-aside designation and the ultimate completion date is August 14, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain network to deliver critical medical commodities like prescription medications, vaccines, and medical equipment to various federal agencies and healthcare programs.

Generated 11/12/24, 9:11 AM